Here's How Much You'd Have If You Invested $1000 in Idexx Laboratories a Decade Ago
Another factor that can influence investors is FOMO, or the fear of missing out, especially with tech giants and popular consumer-facing stocks.
What if you'd invested in Idexx Laboratories (IDXX) ten years ago? It may not have been easy to hold on to IDXX for all that time, but if you did, how much would your investment be worth today?
With that in mind, let's take a look at Idexx Laboratories' main business drivers.
Headquartered in Westbrook, ME, IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.IDEXX operates through four segments:Companion Animal Group (CAG) (91.7% of revenues in 2024, up 1.0% from 2023): This segment provides veterinarians with diagnostic capabilities and information management solutions that enhance the health and well-being of pets. The complementary nature of these products and services provides a unique competitive advantage known as the IDEXX Diagnostic Advantage, providing vets with the tools and services necessary to offer advanced veterinary medical care.Water (4.7%, up 2.2%): Through this segment, IDEXX provides innovative testing solutions for easy, rapid and accurate detection and quantification of various microbiological parameters in water, helping ensure water safety for people worldwide.Livestock, Poultry and Dairy (LPD) (3.1%, down 6.0%): Within this segment, IDEXX provides diagnostic tests and related instrumentation required to manage the health status of livestock and poultry to improve bovine reproductive efficiency and ensure the quality and safety of milk and food. These products are purchased by the government and private laboratories that provide testing services to cattle, swine and poultry veterinarians, producers and processors.Other (0.4%, down 20.0%): The company's OPTI Medical operating segment has been combined and presented with the remaining pharmaceutical product line and the out-licensing arrangements in an 'Other' category, primarily because they do not meet the quantitative or qualitative thresholds for reportable segments.
Anyone can invest, but building a successful investment portfolio requires research, patience, and a little bit of risk. So, if you had invested in Idexx Laboratories ten years ago, you're likely feeling pretty good about your investment today.
According to our calculations, a $1000 investment made in July 2015 would be worth $8,709.45, or a gain of 770.95%, as of July 8, 2025, and this return excludes dividends but includes price increases.
Compare this to the S&P 500's rally of 199.33% and gold's return of 176.69% over the same time frame.
Analysts are anticipating more upside for IDXX.
IDEXX's robust strategic execution is highlighted by new business gains, high customer retention levels and solid net price realization. This underscores the consistent growth in the CAG international business, supported by volume gains and global premium instrument placements. The company's software solutions are facilitating growth by enhancing clinic workflows and promoting greater utilization of diagnostics. Also, the consumable business boosts its top line. Meanwhile, IDEXX's debt-burdened balance sheet raises concern. The company's wide global presence makes it vulnerable to currency fluctuations. Meanwhile, broader macroeconomic issues are slowing its operations.
The stock has jumped 5.20% over the past four weeks. Additionally, no earnings estimate has gone lower in the past two months, compared to 3 higher, for fiscal 2025; the consensus estimate has moved up as well.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
IDEXX Laboratories, Inc. (IDXX) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Duolingo (DUOL) Reports US$252 Million Q2 2025 Sales Growth
Duolingo recently announced impressive Q2 2025 earnings growth, with sales reaching $252 million and net income rising to $45 million, significantly up from the previous year. Despite this strong performance, the company's stock price declined 10% over the past month. This downward movement occurred amid a mixed market backdrop, where major indices like the S&P 500 experienced minor fluctuations yet remained close to record highs. The robust financial results from Duolingo did not seem to counterbalance broader market trends or investor apprehensions concerning economic conditions and potential interest rate changes, contributing to the stock's decline. Every company has risks, and we've spotted 1 warning sign for Duolingo you should know about. Find companies with promising cash flow potential yet trading below their fair value. Despite Duolingo's strong Q2 2025 earnings, with sales hitting US$252 million and net income climbing to US$45 million, the recent 10% decline in the stock price highlights investor concerns beyond immediate financial performance. However, over the longer-term, Duolingo shares have surged 241.62% in three years, showcasing resilience and growth potential amidst broader market fluctuations. Additionally, over the past year, Duolingo outperformed the US Consumer Services industry, which returned 18.6% during the same period. This indicates that while short-term share price movement may reflect transitory market apprehensions, the company's long-term prospects remain robust. The recent earnings announcement underlines the potential impact on future revenue and earnings forecasts, particularly if Duolingo continues expanding into international markets like China and broader Asia. With expected annual revenue growth of 23.2% and earnings forecasted to grow 36.63% per year, the company appears well-positioned for sustained performance improvement. The decline in share price presents a contrasting scenario to the analyst consensus price target of US$497.24, which is significantly above the current price of US$326.93, suggesting potential upside if market conditions stabilize. Dive into the specifics of Duolingo here with our thorough balance sheet health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include DUOL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Boston Globe
an hour ago
- Boston Globe
Somehow the stock market just keeps climbing, despite tariffs and inflation fears
For the time being, the economic reality of tariffs has yet to catch up with the market's earlier worries. Corporate profits remain strong, and the economy, despite worries about what's to come, is still solid. There are pockets of weakness, but the biggest companies that drive the S&P 500's performance have been largely insulated against further impact from tariffs, propelled instead by the growth of artificial intelligence. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up 'There is a case to be made there that we are through the worst of it,' said Stuart Kaiser, an equity strategist at Citigroup. Advertisement With most companies in the S&P 500 having already reported earnings for the three months through June, the average growth rate of the companies in the index nudged into double digits for the third quarter in a row, according to data from FactSet. Bloomberg Big tech companies again led the way, helping to justify their high stock prices. A further contraction in the energy sector, alongside the continued malaise for manufacturers, paled in comparison with the growth of the tech juggernauts. Advertisement And while retailers and other companies that deal directly with consumers have complained about tariffs, the broad message among the big businesses that make up the S&P 500 is that they are manageable. 'This earnings season has allayed a lot of fears,' said Nelson Yu, head of equities at Alliance Bernstein. At the end of the first quarter, just 17% of companies raised their expectations for how they would perform going forward, according to Citi. Many executives simply refrained from offering financial projections, citing uncertainty surrounding the Trump administration's tariff policies. But this quarter, more than 40% of companies in the index raised their earnings estimates, anticipating a more favorable environment than previously expected. 'Companies are telling you they have more clarity, because otherwise they wouldn't provide that guidance,' Kaiser said. Companies, much like investors, loathe uncertainty because it prevents planning and making major decisions. At least with the tariffs roughly in place, there is a sense among executives that the picture is becoming clearer. This month, Citi raised its forecast for where the S&P 500 will finish the year, joining Bank of America, Goldman Sachs, Deutsche Bank and others that raised their targets recently. Those forecasts, however, cluster around where the index stands now -- mostly between 6,300 and 6,600, with Thursday closing at 6,469 -- pointing to an expectation that the rally will slow the rest of the year and underscoring lingering concerns. The recovery from the stock sell-off in April is less pronounced in other indexes. The Russell 2000, which is made up of smaller companies less able to absorb the effects of higher tariffs, is just one index that hasn't shown the same roaring recovery as the S&P 500. Advertisement The Russell turned positive for the year after this past week's inflation report showed only a modest impact so far from tariffs, cementing expectations that the Fed will soon cut interest rates as it starts to slowly take the brakes off the economy -- albeit more slowly than the president would like. Falling interest rates are generally seen as positive for the stock market, but if inflation speeds up significantly, the central bank will be less inclined to keep cutting rates, tempering the forecast for many of the companies that make up the Russell 2000 (and even some in the S&P 500). That wariness has kept many larger fund managers from diving back into the stock market as enthusiastically as retail investors have, according to research from Deutsche Bank. If those hesitant investors return to the market, that could add a tail wind in the second half of the year. But the lack of activity also underlines that not everyone is convinced that the current rally is sustainable. 'The broader group outside of retail is more cautious, more neutral,' said Parag Thatte, an equity strategist at Deutsche Bank. Even neutral is a much rosier sentiment than just a few months ago. After the S&P 500 rose more than 20% for two consecutive years, worries that this year was going to be something of a reckoning for the market have faded. 'We don't see any big cracks developing or any reason to think that the trends of the last few years are now broken,' Thatte said. This article originally appeared in Advertisement
Yahoo
2 hours ago
- Yahoo
History Shows That Palantir Stock's Monster Run Is Speeding Toward an Epic Crash -- and It All Might Come Down to 1 Detail That No One Is Talking About
Key Points Palantir stock is surging thanks to the company's ability to consistently deliver record-breaking growth from its artificial intelligence (AI) products. While it's tempting to follow momentum, Palantir is trading at valuations that eclipse even those seen during prior stock market bubbles. Institutional investors appear to be reining in their buying activity. 10 stocks we like better than Palantir Technologies › As of the closing bell on Aug. 12, shares of data mining darling Palantir Technologies (NASDAQ: PLTR) have skyrocketed by 147% year to date -- making it the top-performing stock in the S&P 500 for two years running. The obvious talking point here is that Palantir has been on a monster run throughout the course of the artificial intelligence (AI) revolution. Skeptics point to Palantir's lofty valuation as the cornerstone of the bear argument, as the stock trades at levels encroaching on dot-com-era bubble territory. While that's true, such concerns haven't stopped the stock from repeatedly notching new highs. I think there is a far subtler detail surrounding Palantir stock that rarely gets discussed. If history is any guide, it could set the stage for an epic reversal. Is now the time to sell Palantir stock? Read on to find out. Valuation that redefines what it means to be "expensive" During the late 1990s, internet companies were often measured by non-financial metrics based on user engagement. Businesses such as Amazon, Cisco, Microsoft, Alphabet, and Yahoo! were valued based on eyeballs and clicks rather than sales and profits. At the peak of dot-com euphoria, many of these internet pioneers traded at price-to-sales (P/S) multiples between 30 and 40 -- considered unsustainably high at the time. Palantir has completely redefined how next-generation technology businesses are valued, though. As of Aug. 12, Palantir boasts a market cap of nearly $444 billion -- larger than Salesforce, SAP, and Adobe, which are far more mature, diversified businesses. Perhaps even more striking is that Palantir's P/S of 137 exists in its own stratosphere -- completely outside the dimensions of its software-as-a-service (SaaS) peers. Some argue that traditional valuation methodologies such as P/S or earnings multiples don't fully capture Palantir's true value or its full potential. Instead, they urge investors to focus on industry-specific and financially engineered metrics such as the Rule of 40 to see just how "cheap" Palantir stock really is. I think this argument is flawed. There's a more telling metric -- and one that almost nobody talks about -- that makes me think Palantir stock could be on a collision course with history. Is "smart money" trying to tell us something? The chart below tracks buying activity in Palantir stock across institutional investors since its initial public offering (IPO) in late 2020. Initially, there was a wave of "smart money" buying during early 2021, which was met with substantial selling during the latter half of that year. Palantir's institutional ownership picked up again following the company's splash into the AI realm a couple of years ago. It's this dynamic where I think the retail investing crowd is missing the bigger picture and buying into a mirage. As the chart above illustrates, there is a convergence happening between the institutional buying and selling in Palantir stock. When net demand tightens -- meaning that buying is no longer materially higher than selling -- it takes less downside pressure to inspire a precipitous drop in share price. I see the dynamics illustrated in the chart above as an inflection point for Palantir stock. In addition, banks, wealth management firms, mutual funds, and hedge funds all have different priorities. Many of these institutions are required to hold large-cap stocks for benchmarking purposes, not because they think the stock is undervalued or because they carry some "diamond hands" conviction that shares are going higher despite abnormal volatility in the present. When a stock becomes an abnormally high weight relative to the overall portfolio, institutional investors often trim their exposure. This is known as portfolio rebalancing. This scenario can be perfectly explained in the video clip above in which mutual fund billionaire Ron Baron describes his fiduciary responsibility to take profits from time to time in even his highest-conviction positions, such as Tesla. If a stock becomes overinflated, institutions will use this market liquidity as a mechanism to sell their shares to retail at a premium. This dynamic is more colloquially referred to leaving retail "holding the bag" when the hype narrative fades. While I can't say for certain where Palantir stock is headed, my thought is that fund investors are going to pressure portfolio managers to trim exposure to Palantir and take some money off the table, much like what Baron experienced. I think the pressure will be rooted in the anticipation of a valuation reset for Palantir given its frothy positioning relative to peers. Will history repeat itself? Although history is not always a perfect predictor, I think it's a strong barometer in this case. While it's virtually impossible to pick the perfect time to sell a stock, I think there are some compelling -- and overlooked -- details that suggest Palantir stock could be headed lower from current price points sooner than many bulls expect. Should you buy stock in Palantir Technologies right now? Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* Now, it's worth noting Stock Advisor's total average return is 1,070% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Adam Spatacco has positions in Alphabet, Amazon, Microsoft, Palantir Technologies, and Tesla. The Motley Fool has positions in and recommends Adobe, Alphabet, Amazon, Cisco Systems, Cloudflare, CrowdStrike, Datadog, Microsoft, MongoDB, Palantir Technologies, Salesforce, ServiceNow, Snowflake, Tesla, and Zscaler. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. History Shows That Palantir Stock's Monster Run Is Speeding Toward an Epic Crash -- and It All Might Come Down to 1 Detail That No One Is Talking About was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
